Latest Drug approvals News

Whitmer orders state to prep for vaccinating kids ages 5-11

Oct. 26, 2021 16:52 PM EDT

LANSING, Mich. (AP) — Michigan Gov. Gretchen Whitmer on Tuesday directed the state to ensure that Pfizer's COVID-19 vaccine for children ages 5-11 will be quickly available if the federal government gives it the green light. Her directive came the same day an advisory...

China to start vaccinating children to age 3 as cases spread

Oct. 25, 2021 10:34 AM EDT

TAIPEI, Taiwan (AP) — Children as young as 3 will start receiving COVID-19 vaccines in China, where 76% of the population has been fully vaccinated and authorities are maintaining a zero-tolerance policy toward outbreaks. China becomes one of the very few countries in...

California officials prepare to vaccinate children age 5-11

Oct. 21, 2021 13:08 PM EDT

LOS ANGELES (AP) — Public health departments across California are gearing up to administer coronavirus vaccines to children ages 5 to 11 in the coming weeks and officials say they are planning "family-friendly" events — including at schools — to persuade parents and guardians to get...

Maryland congressman says he prescribes ivermectin for COVID

Oct. 20, 2021 19:07 PM EDT

BALTIMORE (AP) — A Maryland congressman who is a practicing anesthesiologist said on a radio show that he prescribed a medication typically used to treat parasites in livestock and humans as a treatment for COVID-19. Republican Rep. Andy Harris, who represents...

White House details plans to vaccinate 28M children age 5-11

Oct. 20, 2021 16:01 PM EDT

WASHINGTON (AP) — Children ages 5 to 11 will soon be able to get a COVID-19 shot at their pediatrician's office, local pharmacy and potentially even their school, the White House said Wednesday as it detailed plans for the expected authorization of the Pfizer shot for elementary school...

Biogen CEO: 'Major bottleneck' still limits Alzheimer's drug

Oct. 20, 2021 13:41 PM EDT

A new Alzheimer’s drug from Biogen brought in only $300,000 in sales during its first full quarter on the market, extending a slow debut complicated by coverage questions and doctor concerns. The infused drug, hailed as a potential breakthrough treatment for a fatal...

Gates Foundation to spend $120M on access for COVID-19 pill

Oct. 20, 2021 10:49 AM EDT

The Bill and Melinda Gates Foundation says it will spend $120 million to boost access to generic versions of drugmaker Merck’s antiviral COVID-19 pill for lower income countries, if the drug gets approved by regulators. The private foundation said in a statement...

In quiet debut, Alzheimer's drug finds questions, skepticism

Oct. 17, 2021 09:14 AM EDT

The first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it more than four months ago, but its rollout has been slowed by questions about its price and how well it works. Several major medical centers remain...

Lawsuits demand unproven ivermectin for COVID patients

Oct. 16, 2021 15:35 PM EDT

NEW YORK (AP) — Mask rules, vaccination mandates and business shutdowns have all landed in the courts during the COVID-19 outbreak, confronting judges with questions of science and government authority. Now they are increasingly being asked to weigh in on the deworming drug ivermectin. ...

The Latest: Maine vaccine mandate opponents file appeal

Oct. 15, 2021 20:58 PM EDT

MAINE — Opponents of a COVID-19 vaccine mandate for health care workers in Maine filed an emergency appeal to the U.S. Supreme Court after being dealt another legal defeat on Friday. The appeal was filed hours after the U.S. 1st Circuit Court of Appeals in Boston denied...